Amylyx Pharmaceuticals, Inc. (AMLX): Shares Outstanding
109.88M
As of 2025-12-31
111.37M
As of 2026-06-30
+18.2%
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 109.88M | +60.1% | 2026-03-03, Balance as of period end |
| 2024-12-31 | 68.63M | +1.4% | 2026-03-03, Balance as of period end |
| 2023-12-31 | 67.71M | +1.8% | 2025-03-04, Balance as of period end |
| 2022-12-31 | 66.51M | +847.4% | 2024-02-22, Balance as of period end |
| 2021-12-31 | 7.02M | n/a | 2023-03-13, Balance as of period end |